Aptiv Solutions
Pioneering Adaptive Clinical Trial Solutions for Breakthrough Therapies
Pioneering Adaptive Clinical Trial Solutions for Breakthrough Therapies
Aptiv Solutions, operating as a clinical research organization, focuses on offering adaptive trial design, simulation, and execution; early phase development consulting; pre-clinical development; and drug development services. The company also provides regulatory compliance consulting, including strategy development, agency advisory, legal representation, and submission management services. Specializing in oncology, cardiology, dermatology, respiratory, and orphan diseases, Aptiv Solutions developed AptivAdvantage, an integrated technology platform for executing adaptive clinical trials. Formerly known as Averion International Corp., the company changed its name to Aptiv Solutions, Inc. in February 2011. Founded in 1983 and headquartered in Reston, Virginia, it also has an office in Durham, North Carolina. The latest recorded investment was a $5.66M Debt Financing investment on April 30, 2012. This showcases the company's commitment to pioneering adaptive clinical trial solutions for breakthrough therapies in the Biopharma, Biotechnology, and Pharmaceutical industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Debt Financing | $5.66M | - | 30 Apr 2012 | |
| Seed Round | Unknown | 1 |
|
16 Feb 2011 |
No recent news or press coverage available for Aptiv Solutions.
We care about your data, and we'd love to use cookies make your experience better.
